ACSL4 and ischemic stroke: Additionally, in a mouse model of ischemic stroke, ACSL4 is upregulated after ischemia–reperfusion, and blocking ACSL4 via small-molecule inhibitors (e.g., rosiglitazone) reduces iron accumulation, oxidative stress, and ferroptotic markers, thereby improving neurological recovery [346].